公开(公告)号：EP4370101A1

公开(公告)日：2024-05-22

申请号：EP22751065.8

申请日：2022-07-15

Applicant: Adamed Pharma S.A. ,  Midas Pharma GmbH

Inventor： RZASA, Joanna ,  CADONAU, Stephanie

IPC: A61K9/16 ,  A61K9/48 ,  A61K31/4184 ,  A61K31/4422 ,  A61K31/549 ,  A61K47/36

CPC classification number: A61K9/4866 ,  A61K9/1641 ,  A61K47/36 ,  A61K31/4184 ,  A61K31/4422 ,  A61K31/549

公开(公告)号：EP4331586A1

公开(公告)日：2024-03-06

申请号：EP22193333.6

申请日：2022-08-31

Applicant: Adamed Pharma S.A.

Inventor： Berdzik-Kalarus, Sylwia ,  Owczarz-Rabiega, Malgorzata

IPC: A61K31/5377 ,  A61K31/616 ,  A61P9/10 ,  A61K9/24

Abstract: The present invention relates to an oral fixed-dose immediate release pharmaceutical composition of 2.5 mg of rivaroxaban and 50 mg of acetylsalicylic acid for use in a prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers or for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) and/or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events.

公开(公告)号：EP4032530A1

公开(公告)日：2022-07-27

申请号：EP21153203.1

申请日：2021-01-25

Applicant: Adamed Pharma S.A.

Inventor： Trela, Jolanta ,  Kubiak, Bartlomiej ,  Kiryluk, Anna ,  Niemczyk, Katarzyna

IPC: A61K9/24 ,  A61K31/4178 ,  A61P31/04

Abstract: The present invention relates to a prolonged-release pharmaceutical composition of furazidin for oral administration, which can be used for treating urinary tract infections (UTI). The prolonged-release pharmaceutical composition for oral administration comprises: a) an immediate release component, comprising furazidin and one or more pharmaceutically acceptable excipients; and b) a modified-release component, comprising furazidin, a controlled-release agent, and one or more pharmaceutically acceptable excipients.

公开(公告)号：EP3854384A1

公开(公告)日：2021-07-28

申请号：EP20461508.2

申请日：2020-01-27

Applicant: Adamed Pharma S.A.

Inventor： WOS-LATOSI, Katarzyna ,  GARBERA, Kamil

IPC: A61K9/107 ,  A61K31/58 ,  A61K9/16 ,  A61K9/20 ,  A61K9/48 ,  A61K47/02 ,  A61K47/14 ,  A61P35/00

Abstract: The present invention relates to a pharmaceutical formulation comprising a solidified self-microemulsifyng drug delivery system (SEDDS) of Abiraterone acetate, wherein the system is completely absorbed into a mesoporous material that acts as a functional carrier for the system creating a stable solid oral formulation comprising Abiraterone acetate in a non-crystalline form, and a process of preparing thereof. The pharmaceutical formulation can be used for manufacturing stable solid oral dosage forms of Abiraterone acetate.

公开(公告)号：EP3598968A1

公开(公告)日：2020-01-29

申请号：EP18461589.6

申请日：2018-07-23

Applicant: Adamed Pharma S.A.

Inventor： GARBERA, Kamil ,  RZASA, Joanna

IPC: A61K9/16 ,  A61K9/20 ,  A61K31/439

Abstract: The present invention relates to a solid pharmaceutical composition of cytisine for oral administration in the form of a granulate comprising cytisine, a binder and a porous carrier and a method for the preparation of the granulate.

公开(公告)号：EP4512392A2

公开(公告)日：2025-02-26

申请号：EP24192299.6

申请日：2021-11-30

Applicant: Adalvo Limited ,  Adamed Pharma S.A.

Inventor： BOLTROMIUK, Tomasz

IPC: A61K9/20

Abstract: the present invention relates to a bilayer tablet for oral administration comprising (1) a first modified release layer comprising tamsulosin or a pharmaceutically acceptable salt thereof and a matrix forming polymer and (2) a second immediate release layer comprising solifenacin or a pharmaceutically acceptable salt thereof and at least one water-insoluble diluent, wherein the tablet is optionally film coated.

公开(公告)号：EP4281048A1

公开(公告)日：2023-11-29

申请号：EP22702430.4

申请日：2022-01-24

Applicant: Adamed Pharma S.A.

Inventor： TRELA, Jolanta ,  KUBIAK, Bartlomiej ,  KIRYLUK, Anna ,  NIEMCZYK, Katarzyna

IPC: A61K9/24 ,  A61K31/4178 ,  A61P31/04

公开(公告)号：EP4255398A1

公开(公告)日：2023-10-11

申请号：EP21819877.8

申请日：2021-11-30

Applicant: Adamed Pharma S.A. ,  Adalvo Limited

Inventor： BOLTROMIUK, Tomasz

IPC: A61K9/20

公开(公告)号：EP4106733A2

公开(公告)日：2022-12-28

申请号：EP21711393.5

申请日：2021-02-10

Applicant: Adamed Pharma S.A.

Inventor： RZASA, Joanna ,  WÓS-LATOSI, Katarzyna ,  CIEPLUCHA. Agnieszka

IPC: A61K9/20 ,  A61K9/16 ,  A61K31/00 ,  A61K45/06

公开(公告)号：EP4072517A1

公开(公告)日：2022-10-19

申请号：EP20820856.1

申请日：2020-12-06

Applicant: Adamed Pharma S.A.

Inventor： KUBIAK, Bartlomiej ,  RZASA, Joanna ,  ZARZYCKA, Mariola ,  GARBERA, Kamil

IPC: A61K9/00 ,  A61K31/00 ,  A61K47/02 ,  A61K47/10 ,  A61K47/18 ,  A61K47/26 ,  A61K47/36 ,  A61K47/38 ,  A24B15/00 ,  A61P25/00